Development of a Surface Plasmon Resonance Assay for the Characterization of Small-Molecule Binding Kinetics and Mechanism of Binding to Kynurenine 3-Monooxygenase.
Kynurenine 3-monooxygenase (KMO), a pivotal enzyme in the kynurenine pathway, was identified as a potential therapeutic target for treating neurodegenerative and psychiatric disorders. In this article, we describe a surface plasmon resonance (SPR) assay that delivers both kinetics and the mechanism of binding (MoB) data, enabling a detailed characterization of KMO inhibitors for the enzyme in real time. SPR assay development included optimization of the protein construct and the buffer conditions. The stability and inhibitor binding activity of the immobilized KMO were significantly improved when the experiments were performed at 10°C using a buffer containing 0.05% n-dodecyl-β-d-maltoside (DDM) as the detergent. The KD values of the known KMO inhibitors (UPF648 and RO61-8048) from the SPR assay were in good accordance with the biochemical LC/MS/MS assay. Also, the SPR assay was able to differentiate the binding kinetics (k(a) and k(d)) of the selected unknown KMO inhibitors. For example, the inhibitors that showed comparable IC50 values in the LC/MS/MS assay displayed differences in their residence time (τ = 1/k(d)) in the SPR assay. To better define the MoB of the inhibitors to KMO, an SPR-based competition assay was developed, which demonstrated that both UPF648 and RO61-8048 bound to the substrate-binding site. These results demonstrate the potential of the SPR assay for characterizing the affinity, the kinetics, and the MoB profiles of the KMO inhibitors.
1 Neuroinflammation Biology DBU, Lundbeck Research USA, Inc. , Paramus, New Jersey.
Suresh B
SB
Poda
2 Structural Biology , ZoBio. BV, Leiden, The Netherlands .
Masakazu
M
Kobayashi
2 Structural Biology , ZoBio. BV, Leiden, The Netherlands .
Ruta
R
Nachane
1 Neuroinflammation Biology DBU, Lundbeck Research USA, Inc. , Paramus, New Jersey.
Veena
V
Menon
1 Neuroinflammation Biology DBU, Lundbeck Research USA, Inc. , Paramus, New Jersey.
Adarsh S
AS
Gandhi
1 Neuroinflammation Biology DBU, Lundbeck Research USA, Inc. , Paramus, New Jersey.
David P
DP
Budac
3 Discovery Chemistry and DMPK , Lundbeck A/S, Copenhagen, Denmark .
Guiying
G
Li
1 Neuroinflammation Biology DBU, Lundbeck Research USA, Inc. , Paramus, New Jersey.
Brian M
BM
Campbell
3 Discovery Chemistry and DMPK , Lundbeck A/S, Copenhagen, Denmark .
Lena
L
Tagmose
D000818:Animals; D001665:Binding Sites / Q000502:physiology; D004791:Enzyme Inhibitors / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology; D057809:HEK293 Cells; D006801:Humans; D007313:Insecta; D007700:Kinetics; D050601:Kynurenine 3-Monooxygenase / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D054852:Small Molecule Libraries / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology*; D020349:Surface Plasmon Resonance / Q000379:methods*; D053719:Tandem Mass Spectrometry / Q000379:methods
D004791:Enzyme Inhibitors; D054852:Small Molecule Libraries; D050601:Kynurenine 3-Monooxygenase